Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on OTC Markets

Here is a table of 6 OTC cannabis stocks that are developing cannabis compound medicines.

6 Cannabis Pharma Stocks - OTC Markets
Name & Monthly Returns	Symbol	Recent Prices & Trendline Chart
Axim Biotechnologies	AXIM
Cannabics Pharmaceuticals	CNBX
GB Sciences	GBLX
OWC Pharmaceutical Research	OWCP
PharmaCyte Biotech	PMCB
Vitality Biopharma	VBIO
Price charts from Alpha Vantage as of most recent close.

Portfolio Values

To inspect the performance of the Cannabis Pharma Stocks - OTC Markets portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 5 stocks included in the portfolio computations are: AXIM, CNBX, GBLX, PMCB and VBIO. The current value of the portfolio assumes that $2,000.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. OWCP was excluded from the portfolio computations because of insufficient price data.

The current value of the $10,000 investment is $516. The percent return is -94.84%. The annualized return is -44.73%.

5 Cannabis Pharma Stocks - OTC Markets Returns
Name	Symbol	% Return & Details
Axim Biotechnologies	AXIM	-99.33%
Cannabics Pharmaceuticals	CNBX	-97.83%
GB Sciences	GBLX	-91.77%
PharmaCyte Biotech	PMCB	-98.19%
Vitality Biopharma	VBIO	-87.10%